Charles Schwab’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $608K | Buy |
617,139
+62,923
| +11% | +$61.9K | ﹤0.01% | 3073 |
|
|
2025
Q1 | $798K | Hold |
554,216
| – | – | ﹤0.01% | 2920 |
|
|
2024
Q4 | $1.22M | Sell |
554,216
-698
| -0.1% | -$1.54K | ﹤0.01% | 2837 |
|
|
2024
Q3 | $916K | Hold |
554,914
| – | – | ﹤0.01% | 2944 |
|
|
2024
Q2 | $1.23M | Buy |
554,914
+496,923
| +857% | +$1.1M | ﹤0.01% | 2849 |
|
|
2024
Q1 | $155K | Hold |
57,991
| – | – | ﹤0.01% | 3264 |
|
|
2023
Q4 | $173K | Hold |
57,991
| – | – | ﹤0.01% | 3290 |
|
|
2023
Q3 | $56.8K | Buy |
+57,991
| New | +$56.8K | ﹤0.01% | 3396 |
|
|
2023
Q2 | – | Sell |
-199,811
| Closed | -$318K | – | 3630 |
|
|
2023
Q1 | $318K | Buy |
199,811
+2,859
| +1% | +$4.55K | ﹤0.01% | 3075 |
|
|
2022
Q4 | $1.23M | Buy |
196,952
+27,126
| +16% | +$169K | ﹤0.01% | 2713 |
|
|
2022
Q3 | $1.14M | Buy |
169,826
+8,011
| +5% | +$53.7K | ﹤0.01% | 2749 |
|
|
2022
Q2 | $1.03M | Buy |
161,815
+9,606
| +6% | +$61.1K | ﹤0.01% | 2782 |
|
|
2022
Q1 | $707K | Buy |
152,209
+71,549
| +89% | +$332K | ﹤0.01% | 2986 |
|
|
2021
Q4 | $404K | Buy |
80,660
+12,577
| +18% | +$63K | ﹤0.01% | 3217 |
|
|
2021
Q3 | $821K | Sell |
68,083
-122,414
| -64% | -$1.48M | ﹤0.01% | 2946 |
|
|
2021
Q2 | $4.03M | Buy |
190,497
+4,315
| +2% | +$91.3K | ﹤0.01% | 2448 |
|
|
2021
Q1 | $5.22M | Buy |
186,182
+4,894
| +3% | +$137K | ﹤0.01% | 2281 |
|
|
2020
Q4 | $4.71M | Buy |
181,288
+3,263
| +2% | +$84.8K | ﹤0.01% | 2245 |
|
|
2020
Q3 | $6.62M | Buy |
178,025
+8,823
| +5% | +$328K | ﹤0.01% | 1932 |
|
|
2020
Q2 | $8.68M | Sell |
169,202
-14,529
| -8% | -$746K | ﹤0.01% | 1727 |
|
|
2020
Q1 | $5.79M | Sell |
183,731
-38,221
| -17% | -$1.21M | ﹤0.01% | 1758 |
|
|
2019
Q4 | $13.2M | Sell |
221,952
-18,742
| -8% | -$1.12M | 0.01% | 1493 |
|
|
2019
Q3 | $8.82M | Buy |
240,694
+52,309
| +28% | +$1.92M | 0.01% | 1672 |
|
|
2019
Q2 | $8.76M | Buy |
188,385
+51,343
| +37% | +$2.39M | 0.01% | 1680 |
|
|
2019
Q1 | $5.5M | Buy |
137,042
+5,069
| +4% | +$204K | ﹤0.01% | 1940 |
|
|
2018
Q4 | $6.07M | Sell |
131,973
-2,563
| -2% | -$118K | ﹤0.01% | 1790 |
|
|
2018
Q3 | $5.97M | Buy |
134,536
+23,147
| +21% | +$1.03M | ﹤0.01% | 1953 |
|
|
2018
Q2 | $4.37M | Buy |
111,389
+15,947
| +17% | +$625K | ﹤0.01% | 2069 |
|
|
2018
Q1 | $6.9M | Buy |
95,442
+4,471
| +5% | +$323K | 0.01% | 1758 |
|
|
2017
Q4 | $5.99M | Sell |
90,971
-872
| -0.9% | -$57.4K | ﹤0.01% | 1825 |
|
|
2017
Q3 | $4.6M | Buy |
91,843
+23,568
| +35% | +$1.18M | ﹤0.01% | 1921 |
|
|
2017
Q2 | $3.16M | Buy |
68,275
+13,146
| +24% | +$608K | ﹤0.01% | 2043 |
|
|
2017
Q1 | $1.95M | Buy |
55,129
+9,478
| +21% | +$335K | ﹤0.01% | 2205 |
|
|
2016
Q4 | $572K | Buy |
45,651
+21,787
| +91% | +$273K | ﹤0.01% | 2605 |
|
|
2016
Q3 | $331K | Sell |
23,864
-17,580
| -42% | -$244K | ﹤0.01% | 2752 |
|
|
2016
Q2 | $410K | Sell |
41,444
-5,106
| -11% | -$50.5K | ﹤0.01% | 2663 |
|
|
2016
Q1 | $788K | Buy |
46,550
+1,001
| +2% | +$16.9K | ﹤0.01% | 2416 |
|
|
2015
Q4 | $1.01M | Buy |
45,549
+1,413
| +3% | +$31.5K | ﹤0.01% | 2381 |
|
|
2015
Q3 | $1.04M | Buy |
44,136
+21,666
| +96% | +$512K | ﹤0.01% | 2367 |
|
|
2015
Q2 | $1.84M | Buy |
22,470
+13,270
| +144% | +$1.09M | ﹤0.01% | 2143 |
|
|
2015
Q1 | $852K | Buy |
9,200
+2,100
| +30% | +$194K | ﹤0.01% | 2434 |
|
|
2014
Q4 | $288K | Buy |
+7,100
| New | +$288K | ﹤0.01% | 2855 |
|